Stage IA2 Endometrial Cancer FIGO 2023 Clinical Trials in Toronto, Ontario

Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study